Observational study for patients with gastric MALT lymphoma
Official title: Establishment of a Cohort for Investigating the Pathophysiology of Gastric MALT Lymphoma
Run by Seoul National University Hospital · NCT06454149 · Data updated 2026-11-12
This study is collecting health information and tissue samples from people with gastric MALT lymphoma to help understand the disease better and support future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 3 sites (Ansan-si, Gyeonggi-do and 2 other locations) |
| Status | Recruiting |
| Started | June 6, 2024 |
| Main results expected | June 5, 2028 |
| Study ends | June 5, 2031 |
| Registry record updated | September 28, 2026 |
| Trial ID | NCT06454149 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals newly diagnosed with gastric MALT lymphoma and those undergoing upper endoscopy for related conditions.
✕Probably not a fit
Patients with a history of gastric or other malignancies or those with uncontrolled chronic illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather clinical data and create a tissue repository for patients diagnosed with gastric MALT lymphoma, as well as for control participants. Patients will provide clinical information and various tissue samples, including saliva, gastric mucosa, and feces. The study will help in understanding the disease better and may contribute to future research and treatment strategies.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of gastric MALT lymphoma and improve future treatment options for patients.
How similar studies have gone: While this approach is observational and may not have direct precedents, similar studies in lymphoma research have shown promise in understanding disease mechanisms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \[MALT lymphoma group\] * Newly diagnosed as gastric MALT lymphoma \[Control group\] * Patients who underwent 1. diagnosed upper endoscopy for dyspepsia and had chronic gastritis, 2. therapeutic upper endoscopy for gastric hyperplastic polyps, or 3. screening upper endoscopy without any symptoms. Exclusion Criteria: * History of gastric or other malignancy * Use of antibiotics or probiotics within 4 weeks * Uncontrolled chronic illnesses
Where it's running
-
Cheol Min Shin
Seongnam-si, Gyeonggi-do, South Korea Recruiting -
Kangbuk Samsung Hospital
Seoul, South Korea Recruiting -
Korea University Ansan Hospital
Ansan-si, Gyeonggi-do, South Korea Not yet recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prebiotic and Probiotic Combo for Constipation Symptoms
This study tests whether adding 1-kestose to a probiotic (BBH112) helps adults with constipation-related symptoms see more relief and better quality of life.
-
Rehabilitation data registry for spinal cord injury in Korea
This study tests whether long‑term disability and function after spinal cord injury can be predicted by combining medical and socioeconomic information gathered during and after inpatient rehabilitation.
-
RSV vaccine safety and immune response in lung transplant patients vs. healthy adults
This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.
-
CD19 CAR-T Therapy for Kids with Refractory Childhood SLE
This study tests whether a patient’s own CD19 CAR-T cells can help children and young adults with severe, hard-to-treat lupus.
-
Remimazolam vs propofol for stable blood pressure during thoracic/abdominal endovascular aortic repair
This trial tests whether remimazolam keeps blood pressure steadier than propofol during TEVAR or EVAR in adults.
-
Transitioning to Adult Care for Kids with Rare Endocrine Disorders
We’re testing a structured transition program to help young adults move from pediatric to adult endocrine care and see if it improves staying in care and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.